Mimedx (MDXG) Cash from Investing Activities Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.10% |
| Dec 31, 2025 | 31.81% |
| Sep 30, 2025 | -49.25% |
| Jun 30, 2025 | -12.79% |
| Mar 31, 2025 | 17.86% |
| Dec 31, 2024 | -28.39% |
| Sep 30, 2024 | -44.04% |
| Jun 30, 2024 | -22.36% |
| Mar 31, 2024 | -69.31% |
| Dec 31, 2023 | 16.51% |
| Sep 30, 2023 | 23.35% |
| Jun 30, 2023 | 32.45% |
| Mar 31, 2023 | 26.27% |
| Dec 31, 2022 | -6.37% |
| Sep 30, 2022 | 23.14% |
| Jun 30, 2022 | 24.76% |
| Mar 31, 2022 | 31.33% |
| Dec 31, 2021 | 23.91% |
| Sep 30, 2021 | 19.67% |
| Jun 30, 2021 | -22.30% |
| Mar 31, 2021 | 25.87% |
| Dec 31, 2020 | -27.94% |
| Sep 30, 2020 | 8.47% |
| Jun 30, 2020 | -32.95% |
| Mar 31, 2020 | -0.71% |
| Dec 31, 2019 | 39.58% |
| Sep 30, 2019 | 34.24% |
| Jun 30, 2019 | 16.23% |
| Mar 31, 2019 | 7.34% |
| Dec 31, 2018 | -19.29% |
| Sep 30, 2018 | -16.58% |
| Jun 30, 2018 | -13.35% |
| Mar 31, 2018 | -111.43% |
| Dec 31, 2017 | -39.79% |
| Sep 30, 2017 | -53.54% |
| Jun 30, 2017 | -56.14% |
| Mar 31, 2017 | -83.33% |
| Dec 31, 2016 | -54.39% |
| Sep 30, 2016 | -44.58% |
| Jun 30, 2016 | 38.83% |
| Mar 31, 2016 | -85.02% |